Eyebright Medical Technology Beijing Co Ltd
SSE:688050
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
65.69
195.3119
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Eyebright Medical Technology Beijing Co Ltd
Eyebright Medical Technology Beijing Co Ltd
PP&E Net
Eyebright Medical Technology Beijing Co Ltd
PP&E Net Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | PP&E Net | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Eyebright Medical Technology Beijing Co Ltd
SSE:688050
|
PP&E Net
¥1.4B
|
CAGR 3-Years
70%
|
CAGR 5-Years
59%
|
CAGR 10-Years
N/A
|
|
|
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
|
PP&E Net
¥7.3B
|
CAGR 3-Years
5%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
Autobio Diagnostics Co Ltd
SSE:603658
|
PP&E Net
¥4.1B
|
CAGR 3-Years
16%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
|
Winner Medical Co Ltd
SZSE:300888
|
PP&E Net
¥4.2B
|
CAGR 3-Years
41%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
PP&E Net
¥1.4B
|
CAGR 3-Years
19%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
Intco Medical Technology Co Ltd
SZSE:300677
|
PP&E Net
¥9.4B
|
CAGR 3-Years
9%
|
CAGR 5-Years
57%
|
CAGR 10-Years
N/A
|
|
Eyebright Medical Technology Beijing Co Ltd
Glance View
Eyebright Medical Technology (Beijing) Co., Ltd. engages in the research and development, production, sales and related services of ophthalmic medical equipment and devices. The company is headquartered in Beijing, Beijing and currently employs 579 full-time employees. The company went IPO on 2020-07-29. Its main products include ophthalmic surgery and optometry. Surgical products mainly include intraocular lens, capsular tension ring, intraocular lens implantation system, ophthalmic viscoelastic agent, various types of ophthalmic microsurgical instruments and ophthalmic scalpels, and optometry products include corneal orthopaedics (night-wear type), hard contact lens (daily-wear type) and tear test paper, among others. The firm conducts its businesses in domestic and overseas markets.
See Also
What is Eyebright Medical Technology Beijing Co Ltd's PP&E Net?
PP&E Net
1.4B
CNY
Based on the financial report for Dec 31, 2023, Eyebright Medical Technology Beijing Co Ltd's PP&E Net amounts to 1.4B CNY.
What is Eyebright Medical Technology Beijing Co Ltd's PP&E Net growth rate?
PP&E Net CAGR 5Y
59%
Over the last year, the PP&E Net growth was 77%. The average annual PP&E Net growth rates for Eyebright Medical Technology Beijing Co Ltd have been 70% over the past three years , 59% over the past five years .
You don't have any saved screeners yet
